Johnson & Johnson (NYSE: JNJ) recently reported its Q3 results, with revenues and earnings exceeding our estimates.

Johnson & Johnson's innovative medicines division shows promise with expected revenues of $57bn by 2025. See more about JNJ ...

A jury awarded a Somers man $15 million in compensatory damages Tuesday, siding with claims that years of using Johnson & ...

The article " Johnson & Johnson Stock: Setting the Stage for 2025 Highs " first appeared on MarketBeat.

Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated ...

House Speaker Mike Johnson is taking his "American Revival" tour to the swing states with less than three weeks until ...

“We should all care about health equity because that is one more person who is going to have a challenge to care for their ...

Republicans won 11 of New York’s 26 House seats two years ago, but their number was reduced by one following the expulsion of ...

The denial was the latest loss for the LeRoy Republican convicted of receiving $110,000 in bribes & trysts with a sex worker ...

Utah Forward candidate Laura Johnson faces off against Republican Rod Hall for the Utah Board of Education District 3 seat.

Paul Johnson is standing down as director of the Institute for Fiscal Studies after more than a decade as one of the most ...

Wide receiver Diontae Johnson and linebacker Jadeveon Clowney are two of the headline names on a long Panthers injury report ...